UPDATE 1-CVS chooses Amgen's new cholesterol drug over competitor
November 23, 2015 at 14:54 PM EST
NEW YORK, Nov 23 (Reuters) - U.S. drug benefit manager CVS Health said on Monday it would add Amgen Inc's Repatha cholesterol treatment to its list of covered drugs for private plans over a competing treatment from Regeneron Pharmaceuticals and Sanofi SA.